Article Text
Statistics from Altmetric.com
Footnotes
↵i Could we say that, in attributing these dual goals, we thereby render the components commensurable under the common denominator ‘school excellence’? We could, but it would make commensurability very cheap, undermining the concern Solberg and colleagues identify. I will therefore focus on robust commensurability: commensurability along some dimension beyond the value we place in things.
↵ii In 2012, the Global Burden of Disease Study adopted the hybrid prevalence-incidence calculation method that I prefer, suggesting its authors agree.3
↵iii Murray alternately describes DALYs as true measures of health loss, or of the burden of disease.2 3 There are independent reasons to reject the former view, and the latter strikes me as vague enough to be interpretable in many ways, including as an index.
↵iv Murray (personal communication) has suggested that the DALY’s insistence on categorical causal attribution, according to which each adverse health outcome is (sometimes artificially) assigned to a single cause, may help to prevent advocates for particular issues from manipulating DALYs deceptively.
Contributors SAS is the sole author of this work
Competing interests None declared.
Provenance and peer review Commissioned; internally peer reviewed.
Linked Articles
- Theoretical ethics
- Response
Read the full text or download the PDF:
Other content recommended for you
- The disvalue of death in the global burden of disease
- The world-wide burden of musculoskeletal diseases: a systematic analysis of the World Health Organization Burden of Diseases Database
- Falls in older aged adults in 22 European countries: incidence, mortality and burden of disease from 1990 to 2017
- Direct estimates of disability-adjusted life years lost due to stroke: a cross-sectional observational study in a demographic surveillance site in rural Gadchiroli, India
- Consistency is not overrated
- The global burden of injury: incidence, mortality, disability-adjusted life years and time trends from the Global Burden of Disease study 2013
- Global injury morbidity and mortality from 1990 to 2017: results from the Global Burden of Disease Study 2017
- Global, regional and national burden of rheumatoid arthritis 1990–2017: a systematic analysis of the Global Burden of Disease study 2017
- Estimation of the economic burden of COVID-19 using disability-adjusted life years (DALYs) and productivity losses in Kerala, India: a model-based analysis
- National burden of rheumatoid arthritis in Canada, 1990–2019: findings from the Global Burden of Disease Study 2019 – a GBD collaborator-led study